KickStart30: A 30-Day Intervention for Patients With Rheumatoid Arthritis (RA)
CompletedNot applicableNCT03993548
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study explores the efficacy and feasibility of a self-management wellness intervention that is integrated, prescriptive, and trackable in a population of patients with Rheumatoid Arthritis (RA) taking a biologic. This 30-day wellness intervention (called "KickStart30") combines five wellness elements: exercise, mindfulness, sleep, social connectedness, and nutrition. Additionally, the program requires that participants implement 5 wellness interventions daily for the 30-day study, document daily online adherence, complete daily HERO (happiness, enthusiasm, resilience, and optimism) exercises to improve mental wellness, and complete online program forms before and after the 30-day intervention. Participants are assessed pre- and post-intervention to determine whether the intervention promotes wellness behavior changes.
Study details
- Official title
- KickStart30: A 30-Day Intervention for Patients With Rheumatoid Arthritis (RA)
- Conditions
- Chronic Pain
- Stress
- Psychological
- Healthy
- Rheumatoid Arthritis
- Interventions
- Behavioral: Wellness Element 1 - Exercise
- Behavioral: Wellness Element 2 - Mindfulness
- Behavioral: Wellness Element 3 - Sleep Hygiene
- Behavioral: Wellness Element 4 - Social Connectedness
- Behavioral: Wellness Element 5 - Nutrition
- Behavioral: Wellness Element 6 - Wellness Exercises
- Behavioral: Wellness Element 7 - Motivational Messages
- Sponsor
- University of Texas at Austin
- Start date
- 2019-06-17
- Primary completion
- 2020-03-12
- Sex
- All
- Age range
- from 18 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Diagnosed with Rheumatoid Arthritis (RA) by a Rheumatologist * Currently taking a biologic and/or a JaK inhibitor for the treatment of RA, including one or more of the following: Orencia (intravenous infusion or subcutaneous injection), Humira (subcutaneous injection), Kineret (subcutaneous injection), Cimzia (subcutaneous injection), Enbrel (subcutaneous injection), Simponi (subcutaneous injection), Simponi Aria (intravenous infusion), Remicade (intravenous infusion), Kevzara (subcutaneous injection), Rituxan (intravenous infusion), Actemra (intravenous infusion or subcutaneous injection), Olumiant (oral administration), Xeljanz (oral administration) * Interested in improving overall wellness * Not pregnant and no plans to get pregnant during the 30-day study * English-speaking * Must have access to a reliable Internet-enabled computer * Must possess basic computer skills Exclusion Criteria: * Has not been diagnosed with RA by a Rheumatologist * Not currently taking a biologic or a JAK inhibitor for the treatment of RA * Not interested in improving overall wellness * Pregnant or plans to get pregnant during the 30-day study * Does not speak English * Does not have access to a reliable, Internet-enabled computer * Reports a lack of basic computer skills * Acutely suicidal and/or actively psychotic
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03993548